147 related articles for article (PubMed ID: 37786471)
1. Association between Metabolic Syndrome Risk Factors and Immunohistochemical Profile in Women with Breast Cancer.
Danesh H; Anbiaei R; Ziamajidi N; Farhadian M; Barartabar Z; Abbasalipourkabir R
Iran J Med Sci; 2023 Sep; 48(5):456-464. PubMed ID: 37786471
[TBL] [Abstract][Full Text] [Related]
2. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
Akinyemiju T; Oyekunle T; Salako O; Gupta A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Daramola A
Clin Breast Cancer; 2022 Jun; 22(4):e463-e472. PubMed ID: 34980540
[TBL] [Abstract][Full Text] [Related]
4. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
[TBL] [Abstract][Full Text] [Related]
5. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
7. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
[TBL] [Abstract][Full Text] [Related]
8. The association between healthy lifestyle score and risk of metabolic syndrome in Iranian adults: a cross-sectional study.
Vajdi M; Karimi A; Farhangi MA; Ardekani AM
BMC Endocr Disord; 2023 Jan; 23(1):16. PubMed ID: 36647030
[TBL] [Abstract][Full Text] [Related]
9. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, insulin resistance, and mammographic density in pre- and postmenopausal women.
Kim BK; Chang Y; Ahn J; Jung HS; Kim CW; Yun KE; Kwon MJ; Suh BS; Chung EC; Shin H; Ryu S
Breast Cancer Res Treat; 2015 Sep; 153(2):425-34. PubMed ID: 26277917
[TBL] [Abstract][Full Text] [Related]
11. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
13. Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls.
Sheean P; Liang H; Schiffer L; Arroyo C; Stolley M
J Cancer Surviv; 2017 Feb; 11(1):102-110. PubMed ID: 27562474
[TBL] [Abstract][Full Text] [Related]
14. Predicting metabolic syndrome by anthropometric measures among adults 35-65 years in the west of Iran; a cross sectional study from an Iranian RaNCD cohort data.
Hamzeh B; Bagheri A; Pasdar Y; Darbandi M; Rezaeian S; Najafi F; Moradinazar M
Diabetes Metab Syndr; 2020; 14(5):1293-1298. PubMed ID: 32755824
[TBL] [Abstract][Full Text] [Related]
15. Neck circumference and metabolic syndrome: A cross-sectional population-based study.
Ebrahimi H; Mahmoudi P; Zamani F; Moradi S
Prim Care Diabetes; 2021 Jun; 15(3):582-587. PubMed ID: 33602607
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Obesity on the Waist Circumference Cut-Point Used for the Diagnosis of the Metabolic Syndrome in African Women: Results from the SWEET Study.
Gradidge PJ; Norris SA; Crowther NJ
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011884
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenic obesity in early breast cancer patients with metabolic syndrome: a cross-sectional study.
Bulut G; Atci N
Future Oncol; 2022 Jun; 18(20):2489-2498. PubMed ID: 35543029
[No Abstract] [Full Text] [Related]
19. Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran.
Najafi B; Anvari S; Roshan ZA
Asian Pac J Cancer Prev; 2013; 14(10):5811-6. PubMed ID: 24289582
[TBL] [Abstract][Full Text] [Related]
20. The Relation Between Metabolic Syndrome and Its Components with Breast Density in Postmenopausal Women.
Kaya C; Cengiz H; Alay İ; Örs S; Kaya SE; Ekin M; Yaşar L
Metab Syndr Relat Disord; 2019; 17(6):341-345. PubMed ID: 31045476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
